Stewart S. L., 2004, MMWR. Surveill. Summ., 53, 1
Jemal A., 2002, CA Cancer. J.Clin., 52, 23, 10.3322/canjclin.52.1.23
10.1016/S0959-8049(01)00350-1
10.1016/S0378-5122(00)00196-1
Pike M. C., 1993, Epidemiol. Rev., 15, 17, 10.1093/oxfordjournals.epirev.a036102
Parkin D. M., 1999, CA Cancer J. Clin., 49, 33, 10.3322/canjclin.49.1.33
10.1097/01.ede.0000129512.61698.03
10.1093/carcin/17.11.2279
10.1002/(SICI)1097-0142(19990601)85:11<2400::AID-CNCR15>3.0.CO;2-O
Kelsey J. L., 1993, Epidemiol.Rev., 15, 36, 10.1093/oxfordjournals.epirev.a036115
Titus-Ernstoff L., 1998, Cancer Epidemiol.Biomarkers Prev., 7, 783
Brinton L. A., 1988, Cancer Invest, 6, 245, 10.3109/07357908809080645
10.1016/S0140-6736(96)90806-5
10.1016/S0959-8049(98)00343-8
20. J. Russo, Y. F. Hu, X. Yang, and I. H. Russo , Developmental, cellular, and molecular basis of human breast cancer ,J. Natl. Cancer. Inst. Monogr., 17 -37 , 2000 .
10.1002/(SICI)1097-0142(20000301)88:5+<1230::AID-CNCR9>3.0.CO;2-F
10.1056/NEJM199407073310102
Helewa M., 2002, J. Obstet. Gynaecol. Can., 24, 164, 10.1016/S1701-2163(16)30298-5
10.1016/S0140-6736(02)11032-4
10.1016/S0140-6736(97)08233-0
10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y
10.1016/0010-7824(96)00111-4
10.1016/S0361-090X(02)00004-1
Coutelle C., 2004, Int. J. Oncol., 25, 1127
10.1016/1071-5576(94)00048-6
42. N. C. Onland-Moret, P. H. Peeters, Y. T. Schouw, D. E. Grobbee, and C. H. Gils , Alcohol and Endogenous Sex Steroid Levels in Postmenopausal Women: a cross-sectional study ,J. Clin. Endocrinol. Metab., 2004 .
Sellers T. A., 2002, Cancer Epidemiol. Biomarkers Prev., 11, 1104
10.1097/00001703-200402000-00005
10.1093/carcin/20.12.2209
10.1016/S0002-8223(00)00420-X
10.1046/j.1525-1381.1999.09230.x
Gaudet M. M., 2004, Cancer Epidemiol. Biomarkers Prev., 13, 1485, 10.1158/1055-9965.1485.13.9
10.1097/00008469-200102000-00003
10.1097/00008469-200402000-00002
10.1016/S0140-6736(01)06524-2
10.1097/00008469-200004000-00006
Cauley J. A., 1994, Am. J. Epidemiol., 139, 1035, 10.1093/oxfordjournals.aje.a116943
10.1016/S0140-6736(04)16044-3
Yu H., 2003, Cancer Epidemiol. Biomarkers Prev., 12, 1067
10.1053/j.seminoncol.2004.03.042
Easton D., 1993, Cancer Surv., 18, 95
10.1002/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H
10.1002/(SICI)1097-0142(19991201)86:11+<2493::AID-CNCR6>3.0.CO;2-Z
10.1002/1521-1878(200008)22:8<728::AID-BIES6>3.3.CO;2-2
10.1146/annurev.ge.28.120194.002303
Garber J. E., 1991, Cancer Res., 51, 6094
Easton D. F., 1994, Br. Med. Bull., 50, 527, 10.1093/oxfordjournals.bmb.a072908
Gorski B., 2003, Int. J. Cancer, 106, 379, 10.1002/ijc.11231
10.1016/S0304-419X(00)00021-4
Bartsch H., 2000, Cancer Epidemiol. Biomarkers Prev., 9, 3
98. R. C. Strange, and A. A. Fryer , The glutathione S-transferases: influence of polymorphism on cancer susceptibility ,IARC Sci. Publ., 231 -249 , 1999 .
Albin N., 1993, Cancer Res., 53, 3541
Gudmundsdottir K., 2001, Cancer Epidemiol. Biomakers Prev., 10, 1169
Duell E. J., 2001, Cancer Epidemiol. Biomarkers Prev., 10, 217
Smith T. R., 2003, Cancer Epidemiol. Biomarkers Prev., 12, 1200
Goode E. L., 2002, Cancer Epidemiol. Biomarkers Prev., 11, 1513
10.1158/1078-0432.CCR-031211